Skip to Content
User name: Password:
Remember me:
Browse History
Follow Us
Text Size
10:30 AM
Welcome
Palmer Beasley, Chair
10:35
Surveillance Strengths and Weaknesses
Gary Heseltine, Lead Consultant, Viral Hepatitis Team, Council of State and Territorial Epidemiologists
11:15
Viral Hepatitis Prevention Policies and Programs, Centers for Medicare and Medicaid (CMS)
William Rogers, Director of CMS, Physician's Regulatory Issues Team
12:00 Noon
Lunch
1:00 PM
Community Health Centers: Health Resources and Services Administration (HRSA) Policies and Programs
Tanya Pagan Raggio Ashley, Director, Office of Minority Health and Health Disparities, and Chief Medical Officer, HRSA
1:45
Community Health Centers: Prevention and Care
Carol Craig, Project Coordinator, National Association of Community Health Centers, Inc.*
2:30
Hepatitis C Prevention: Harm Reduction
Daniel Raymond, Policy Director, Harm Reduction Coalition
3:15
Break
3:30
Global Viral Hepatitis Burden: Implications for the U.S. and CDC Response
David Bell, Associate Director for Science and Global Activities, Division of Viral Hepatitis, Centers for Disease Control and Prevention
4:15
Global Control Programs and HBV Immunization
Mark Kane, Former Director of the Children's Vaccine Program, PATH
5:00
Adjourn
*Ms. Craig was unable to attend the meeting, but submitted her presentation to the committee.
Back to Meeting
Keck CenterW822A500 Fifth St. NWWashington, DC 20001